- Forums
- ASX - By Stock
- MSB
- Ann: Novartis and Mesoblast Remestemcel-L Collaboration
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-812
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
0.000(0.00%) |
Mkt cap ! $1.170B |
Open | High | Low | Value | Volume |
0.0¢ | $1.07 | $1.01 | $317.1K | 299.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4642 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 13598 | 1.035 |
7 | 40313 | 1.030 |
10 | 63158 | 1.025 |
8 | 41283 | 1.020 |
7 | 69282 | 1.015 |
Price($) | Vol. | No. |
---|---|---|
1.045 | 41839 | 7 |
1.050 | 83081 | 14 |
1.055 | 93630 | 11 |
1.060 | 132215 | 11 |
1.065 | 25759 | 6 |
Last trade - 09.58am 24/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online